Novel Device to Assess Endotracheal Tube Migration
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01697215|
Recruitment Status : Completed
First Posted : October 2, 2012
Last Update Posted : December 13, 2016
|Condition or disease||Intervention/treatment|
|Mechanically Ventilated Patients Admitted to a MICU||Other: AirWave|
|Study Type :||Observational|
|Actual Enrollment :||50 participants|
|Official Title:||Novel Device (AirWave™) to Assess Endotracheal Tube Migration.|
|Study Start Date :||April 2012|
|Actual Primary Completion Date :||June 2012|
Oral or nasal endotracheal intubation
Oral or nasal endotracheal intubation, anticipated to last at least 48 hours Adults that require ETT internal diameter sizes of 6.5 - 9.0 mm Subject must be at least 18 years old (no upper age limitation) English speaking patients/decision makers.
- Endotracheal tube displacement measured by a novel device (AirWave) [ Time Frame: within 24 hours after intubation. ]
Use of the AirWave in the study group to calculate ETT tip distance from the carina will demonstrate a strong positive correlation with chest x-rays results. Specific endpoints will include:
• Compare CXR tube tip movement/distance to carina measurement results to AirWave tube tip movement/distance to carina calculation results (from the AirWave baseline location) within 24 hours after intubation.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01697215
|United States, Ohio|
|Cleveland, Ohio, United States, 44195|
|Principal Investigator:||Adriano Tonelli, MD||The Cleveland Clinic Foundatin|